{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:59:50Z","timestamp":1787497190026,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Traditional Chinese Medicine Science and Technology Project of Zhejiang Province","award":["No.2024ZL099"],"award-info":[{"award-number":["No.2024ZL099"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82271817"],"award-info":[{"award-number":["No. 82271817"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-024-03437-z","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T02:44:27Z","timestamp":1731984267000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Semaphorin 5A promotes Th17 differentiation via PI3K-Akt-mTOR in systemic lupus erythematosus"],"prefix":"10.1186","volume":"26","author":[{"given":"Xin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanji","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,19]]},"reference":[{"issue":"1","key":"3437_CR1","doi-asserted-by":"publisher","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","volume":"2","author":"A Kaul","year":"2016","unstructured":"Kaul A, Gordon C, Crow MK, Touma Z, Urowitz MB, van Vollenhoven R, Ruiz-Irastorza G, Hughes G. Systemic Lupus Erythematosus. Nat Rev Dis Primers. 2016;2(1):16039. https:\/\/doi.org\/10.1038\/nrdp.2016.39.","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"3437_CR2","doi-asserted-by":"publisher","first-page":"ITC81","DOI":"10.7326\/AITC202006020","volume":"172","author":"M Kiriakidou","year":"2020","unstructured":"Kiriakidou M, Ching CL. Systemic Lupus Erythematosus. Ann Intern Med. 2020;172(11):ITC81\u201396. https:\/\/doi.org\/10.7326\/AITC202006020.","journal-title":"Ann Intern Med"},{"issue":"1","key":"3437_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/rai2.12060","volume":"3","author":"YTV Aw","year":"2023","unstructured":"Aw YTV, Whiley PJ, Lorenzo AM, Lea-Henry T, Shanmuganandam S, Stanley M, Babu SN, Athanasopoulos V, Cappello J, Ellyard JI, et al. Immunophenotyping identifies distinct Cellular signatures for systemic Lupus Erythematosus and Lupus Nephritis. Rheumatol Autoimmun. 2023;3(1):15\u201325. https:\/\/doi.org\/10.1002\/rai2.12060.","journal-title":"Rheumatol Autoimmun"},{"issue":"4","key":"3437_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/rai2.12103","volume":"3","author":"X Shi","year":"2023","unstructured":"Shi X, Wang Z, Tang R, Chen WP. Injury and Death: New insights into Lupus Nephritis Pathogenesis and Therapy. Rheumatol Autoimmun. 2023;3(4):193\u2013204. https:\/\/doi.org\/10.1002\/rai2.12103.","journal-title":"Rheumatol Autoimmun"},{"issue":"10","key":"3437_CR5","doi-asserted-by":"publisher","first-page":"a030338","DOI":"10.1101\/cshperspect.a030338","volume":"10","author":"JT Zhu","year":"2018","unstructured":"Zhu JT. Helper cell differentiation, heterogeneity, and plasticity. Cold Spring Harb Perspect Biol. 2018;10(10):a030338. https:\/\/doi.org\/10.1101\/cshperspect.a030338.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"3","key":"3437_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/rai2.12048","volume":"2","author":"Q Cheng","year":"2022","unstructured":"Cheng Q, Chen X, Xu J, Chen M, Zhang P, Wu H, Du Y. lncRNA X-inactive\u2010specific transcript is a potential biomarker related to changes in CD4 + T cell levels in systemic Lupus Erythematosus. Rheumatol Autoimmun. 2022;2(3):159\u201374. https:\/\/doi.org\/10.1002\/rai2.12048.","journal-title":"Rheumatol Autoimmun"},{"issue":"12","key":"3437_CR7","doi-asserted-by":"publisher","first-page":"8761","DOI":"10.4049\/jimmunol.181.12.8761","volume":"181","author":"JC Crisp\u00edn","year":"2008","unstructured":"Crisp\u00edn JC, Oukka M, Bayliss G, Cohen RA, Van Beek CA, Stillman IE, Kyttaris VC, Juang Y-T, Tsokos GC. Expanded Double Negative T Cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol. 2008;181(12):8761\u20136. https:\/\/doi.org\/10.4049\/jimmunol.181.12.8761.","journal-title":"J Immunol"},{"issue":"2","key":"3437_CR8","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3390\/ijms20020374","volume":"20","author":"S Garcia","year":"2019","unstructured":"Garcia S. Role of semaphorins in Immunopathologies and Rheumatic diseases. IJMS. 2019;20(2):374. https:\/\/doi.org\/10.3390\/ijms20020374.","journal-title":"IJMS"},{"issue":"1","key":"3437_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrrheum.2017.201","volume":"14","author":"M Nishide","year":"2018","unstructured":"Nishide M, Kumanogoh A. The role of Semaphorins in Immune responses and Autoimmune Rheumatic diseases. Nat Rev Rheumatol. 2018;14(1):19\u201331. https:\/\/doi.org\/10.1038\/nrrheum.2017.201.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"3437_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12974-020-01757-w","volume":"17","author":"T Koda","year":"2020","unstructured":"Koda T, Namba A, Kinoshita M, Nakatsuji Y, Sugimoto T, Sakakibara K, Tada S, Shimizu M, Yamashita K, Takata K, et al. Sema4A is implicated in the acceleration of Th17 cell-mediated neuroinflammation in the Effector Phase. J Neuroinflammation. 2020;17(1):82. https:\/\/doi.org\/10.1186\/s12974-020-01757-w.","journal-title":"J Neuroinflammation"},{"issue":"21","key":"3437_CR11","doi-asserted-by":"publisher","first-page":"4989","DOI":"10.1523\/JNEUROSCI.4390-03.2004","volume":"24","author":"JL Goldberg","year":"2004","unstructured":"Goldberg JL, Vargas ME, Wang JT, Mandemakers W, Oster SF, Sretavan DW, Barres BA. An Oligodendrocyte Lineage-Specific Semaphorin, Sema5A, inhibits Axon Growth by Retinal Ganglion cells. J Neurosci. 2004;24(21):4989\u201399. https:\/\/doi.org\/10.1523\/JNEUROSCI.4390-03.2004.","journal-title":"J Neurosci"},{"issue":"7","key":"3437_CR12","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/sj.embor.7400189","volume":"5","author":"S Artigiani","year":"2004","unstructured":"Artigiani S, Conrotto P, Fazzari P, Gilestro GF, Barberis D, Giordano S, Comoglio PM, Tamagnone L. Plexin-B3 is a functional receptor for semaphorin 5A. EMBO Rep. 2004;5(7):710\u20134. https:\/\/doi.org\/10.1038\/sj.embor.7400189.","journal-title":"EMBO Rep"},{"issue":"3","key":"3437_CR13","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.neuron.2011.06.009","volume":"71","author":"RL Matsuoka","year":"2011","unstructured":"Matsuoka RL, Chivatakarn O, Badea TC, Samuels IS, Cahill H, Katayama K-I, Kumar SR, Suto F, Ch\u00e9dotal A, Peachey NS, et al. Class 5 transmembrane Semaphorins Control Selective mammalian retinal lamination and function. Neuron. 2011;71(3):460\u201373. https:\/\/doi.org\/10.1016\/j.neuron.2011.06.009.","journal-title":"Neuron"},{"issue":"5","key":"3437_CR14","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.thromres.2015.07.032","volume":"136","author":"M Lyu","year":"2015","unstructured":"Lyu M, Li Y, Hao Y, Sun T, Liu W, Lyu C, Fu R, Li H, Xue F, Liu X, et al. Elevated semaphorin 5A correlated with Th1 polarization in patients with chronic Immune Thrombocytopenia. Thromb Res. 2015;136(5):859\u201364. https:\/\/doi.org\/10.1016\/j.thromres.2015.07.032.","journal-title":"Thromb Res"},{"issue":"8","key":"3437_CR15","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1530\/EC-17-0132","volume":"6","author":"Y Liu","year":"2017","unstructured":"Liu Y, Wang S, Guo Q, Li Y, Qin J, Zhao N, Li Y, Shan Z, Teng W. Elevated semaphorin 5A in patients with Hashimoto\u2019s Thyroiditis: a case-control study. Endocr Connect. 2017;6(8):659\u201366. https:\/\/doi.org\/10.1530\/EC-17-0132.","journal-title":"Endocr Connect"},{"issue":"3","key":"3437_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/biom11030373","volume":"11","author":"M Lobna","year":"2021","unstructured":"Lobna M, Nasren E, Adi S, Jacob B, Maria G-AA, Marcus M, Zahava V. The expression of IL-17, in chronic spontaneous urticaria is linked to Semaphorin5A. Biomolecules. 2021;11(3):373. https:\/\/doi.org\/10.3390\/biom11030373.","journal-title":"Biomolecules"},{"issue":"2","key":"3437_CR17","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/cei.12924","volume":"188","author":"Y Du","year":"2017","unstructured":"Du Y, Wu X, Chen M, Wang W, Xv W, Ye L, Wu D, Xue J, Sun W, Luo J, et al. Elevated semaphorin5A in systemic Lupus Erythematosus is in Association with Disease Activity and Lupus Nephritis. Clin Exp Immunol. 2017;188(2):234\u201342. https:\/\/doi.org\/10.1111\/cei.12924.","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"3437_CR18","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology Revised Criteria for the classification of systemic Lupus Erythematosus. Arthritis Rheum. 1997;40(9):1725. https:\/\/doi.org\/10.1002\/art.1780400928.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3437_CR19","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/art.38425","volume":"66","author":"C Gras","year":"2014","unstructured":"Gras C, Eiz-Vesper B, Jaimes Y, Immenschuh S, Jacobs R, Witte T, Blasczyk R, Figueiredo C. Secreted semaphorin 5A activates Immune Effector cells and is a biomarker for rheumatoid arthritis: secreted semaphorin 5A in rheumatoid arthritis. Arthritis Rheumatol. 2014;66(6):1461\u201371. https:\/\/doi.org\/10.1002\/art.38425.","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"3437_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3892\/ijo.2022.5311","volume":"60","author":"M-Z Chen","year":"2022","unstructured":"Chen M-Z, Su L-Y, Ko P-H, Hsu M-H, Chuang L-L, Chen L-H, Lu T-P, Chuang EY, Chow L-P, Tsai M-H, et al. Extracellular domain of semaphorin 5A serves a tumor\u2013suppressing role by activating Interferon Signaling pathways in Lung Adenocarcinoma cells. Int J Oncol. 2022;60(2):21. https:\/\/doi.org\/10.3892\/ijo.2022.5311.","journal-title":"Int J Oncol"},{"issue":"7","key":"3437_CR21","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41419-022-05065-4","volume":"13","author":"Q Cheng","year":"2022","unstructured":"Cheng Q, Chen M, Liu M, Chen X, Zhu L, Xu J, Xue J, Wu H, Du Y. Semaphorin 5A suppresses ferroptosis through activation of PI3K-AKT-mTOR signaling in rheumatoid arthritis. Cell Death Dis. 2022;13(7):608. https:\/\/doi.org\/10.1038\/s41419-022-05065-4.","journal-title":"Cell Death Dis"},{"key":"3437_CR22","doi-asserted-by":"publisher","first-page":"115666","DOI":"10.1016\/j.biopha.2023.115666","volume":"168","author":"Y Qin","year":"2023","unstructured":"Qin Y, Jin J, Zhang J, Wang H, Liu L, Zhang Y, Ling S, Hu J, Li N, Wang J, et al. A fully human monoclonal antibody targeting semaphorin 5A alleviates the progression of rheumatoid arthritis. Biomed Pharmacother. 2023;168:115666. https:\/\/doi.org\/10.1016\/j.biopha.2023.115666.","journal-title":"Biomed Pharmacother"},{"key":"3437_CR23","doi-asserted-by":"publisher","first-page":"654912","DOI":"10.3389\/fmed.2021.654912","volume":"8","author":"FC Paquissi","year":"2021","unstructured":"Paquissi FC, Abensur H. The Th17\/IL-17 Axis and kidney diseases, with Focus on Lupus Nephritis. Front Med (Lausanne). 2021;8:654912. https:\/\/doi.org\/10.3389\/fmed.2021.654912.","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"3437_CR24","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1681\/ASN.2017090949","volume":"29","author":"S Krohn","year":"2018","unstructured":"Krohn S, Nies JF, Kapffer S, Schmidt T, Riedel J-H, Kaffke A, Peters A, Borchers A, Steinmetz OM, Krebs CF, et al. IL-17\u00a0C\/IL-17 receptor E signaling in CD4\u2009+\u2009T cells promotes TH17 cell-driven glomerular inflammation. J Am Soc Nephrol. 2018;29(4):1210\u201322. https:\/\/doi.org\/10.1681\/ASN.2017090949.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"3437_CR25","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/cei.12579","volume":"180","author":"D Petrovic-Djergovic","year":"2015","unstructured":"Petrovic-Djergovic D, Popovic M, Chittiprol S, Cortado H, Ransom RF, Partida-S\u00e1nchez S. CXCL10 induces the recruitment of monocyte-derived macrophages into kidney, which aggravate Puromycin Aminonucleoside Nephrosis. Clin Exp Immunol. 2015;180(2):305\u201315. https:\/\/doi.org\/10.1111\/cei.12579.","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"3437_CR26","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1681\/ASN.2006111237","volume":"18","author":"U Panzer","year":"2007","unstructured":"Panzer U, Steinmetz OM, Paust H-J, Meyer-Schwesinger C, Peters A, Turner J-E, Zahner G, Heymann F, Kurts C, Hopfer H, et al. Chemokine receptor CXCR3 Mediates T Cell Recruitment and Tissue Injury in Nephrotoxic Nephritis in mice. J Am Soc Nephrol. 2007;18(7):2071\u201384. https:\/\/doi.org\/10.1681\/ASN.2006111237.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"3437_CR27","doi-asserted-by":"publisher","first-page":"e0178352","DOI":"10.1371\/journal.pone.0178352","volume":"12","author":"G Lu","year":"2017","unstructured":"Lu G, Zhang X, Shen L, Qiao Q, Li Y, Sun J, Zhang J. CCL20 secreted from IgA1-Stimulated Human Mesangial Cells Recruits Inflammatory Th17 Cells in IgA Nephropathy. PLoS ONE. 2017;12(5):e0178352. https:\/\/doi.org\/10.1371\/journal.pone.0178352.","journal-title":"PLoS ONE"},{"issue":"4","key":"3437_CR28","doi-asserted-by":"publisher","first-page":"e12645","DOI":"10.1111\/sji.12645","volume":"87","author":"J Yan","year":"2018","unstructured":"Yan J, Li Y, Yang H, Zhang L, Yang B, Wang M, Li Q. Interleukin-17A participates in Podocyte Injury by inducing IL-1\u03b2 secretion through ROS-NLRP3 inflammasome-Caspase-1 pathway. Scand J Immunol. 2018;87(4):e12645. https:\/\/doi.org\/10.1111\/sji.12645.","journal-title":"Scand J Immunol"},{"issue":"1","key":"3437_CR29","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3892\/etm.2020.8698","volume":"20","author":"S Zhai","year":"2020","unstructured":"Zhai S, Sun B, Zhang Y, Zhao L, Zhang L. IL-17 aggravates renal Injury by promoting Podocyte Injury in Children with primary nephrotic syndrome. Exp Ther Med. 2020;20(1):409\u201317. https:\/\/doi.org\/10.3892\/etm.2020.8698.","journal-title":"Exp Ther Med"},{"key":"3437_CR30","doi-asserted-by":"publisher","unstructured":"L L, Fg L, M Y, L W, Y C, L W, W J, Jm F. Effect of pro-inflammatory Interleukin-17A on epithelial cell phenotype inversion in HK-2 cells in Vitro. Eur Cytokine Netw. 2016;27(2). https:\/\/doi.org\/10.1684\/ecn.2016.0373.","DOI":"10.1684\/ecn.2016.0373"},{"issue":"3","key":"3437_CR31","first-page":"1843","volume":"11","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Chen X, Deng Y. miR-125a-3p decreases levels of Interlukin-17 and suppresses renal fibrosis via down-regulating TGF-\u03921 in systemic lupus erythematosus mediated Lupus Nephritic mice. Am J Transl Res. 2019;11(3):1843\u201353.","journal-title":"Am J Transl Res"},{"issue":"7","key":"3437_CR32","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/s41423-020-00540-4","volume":"18","author":"K Ma","year":"2021","unstructured":"Ma K, Du W, Xiao F, Han M, Huang E, Peng N, Tang Y, Deng C, Liu L, Chen Y, et al. IL-17 sustains the plasma cell response via P38-Mediated Bcl-xL RNA Stability in Lupus Pathogenesis. Cell Mol Immunol. 2021;18(7):1739\u201350. https:\/\/doi.org\/10.1038\/s41423-020-00540-4.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"3437_CR33","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/0961203319891243","volume":"29","author":"M Robert","year":"2020","unstructured":"Robert M, Miossec P. Interleukin-17 and Lupus: enough to be a target? For which patients? Lupus. 2020;29(1):6\u201314. https:\/\/doi.org\/10.1177\/0961203319891243.","journal-title":"Lupus"},{"key":"3437_CR34","doi-asserted-by":"publisher","unstructured":"S J, J H, X Y, T. Cell metabolism: a New Perspective on Th17\/Treg Cell Imbalance in systemic Lupus Erythematosus. Front Immunol. 2020;11. https:\/\/doi.org\/10.3389\/fimmu.2020.01027.","DOI":"10.3389\/fimmu.2020.01027"},{"issue":"4","key":"3437_CR35","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ni.2005","volume":"12","author":"GM Delgoffe","year":"2011","unstructured":"Delgoffe GM, Pollizzi KN, Waickman AT, Heikamp E, Meyers DJ, Horton MR, Xiao B, Worley PF, Powell JD. The kinase mTOR regulates the Differentiation of Helper T Cells through the selective activation of signaling by mTORC1 and mTORC2. Nat Immunol. 2011;12(4):295\u2013303. https:\/\/doi.org\/10.1038\/ni.2005.","journal-title":"Nat Immunol"},{"key":"3437_CR36","doi-asserted-by":"publisher","unstructured":"Li H, Boulougoura A, Endo Y, Tsokos GC. Abnormalities of T cells in systemic Lupus Erythematosus: New insights in Pathogenesis and therapeutic strategies. J Autoimmun. 2022;102870. https:\/\/doi.org\/10.1016\/j.jaut.2022.102870.","DOI":"10.1016\/j.jaut.2022.102870"},{"key":"3437_CR37","doi-asserted-by":"publisher","first-page":"121766","DOI":"10.1016\/j.biomaterials.2022.121766","volume":"289","author":"J Zhang","year":"2022","unstructured":"Zhang J, Guo Q, Dai D, Yu J, Wang L, Wu Z, Ding H, Shen N, Duan Y. Rapamycin-Encapsulated Costimulatory ICOS\/CD40L-Bispecific nanoparticles restrict pathogenic helper T-B-Cell interactions while in situ suppressing mTOR for Lupus Treatment. Biomaterials. 2022;289:121766. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121766.","journal-title":"Biomaterials"},{"key":"3437_CR38","doi-asserted-by":"publisher","first-page":"111289","DOI":"10.1016\/j.biopha.2021.111289","volume":"137","author":"X Song","year":"2021","unstructured":"Song X, Gao J, Liu H, Liu X, Tang K. Rapamycin alleviates renal damage in mice with systemic lupus erythematosus through improving Immune response and function. Biomed Pharmacother. 2021;137:111289. https:\/\/doi.org\/10.1016\/j.biopha.2021.111289.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"3437_CR39","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1093\/rheumatology\/keaa645","volume":"60","author":"C Wu","year":"2021","unstructured":"Wu C, Wang Q, Xu D, Li M, Zeng X. Sirolimus for patients with connective tissue disease-related refractory thrombocytopenia: a Single-Arm, open-label clinical trial. Rheumatology (Oxford). 2021;60(6):2629\u201334. https:\/\/doi.org\/10.1093\/rheumatology\/keaa645.","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"3437_CR40","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.4049\/jimmunol.1301859","volume":"192","author":"H Kato","year":"2014","unstructured":"Kato H, Perl A. Mechanistic Target of Rapamycin Complex 1 expands Th17 and IL-4\u2009+\u2009CD4-CD8- Double-Negative T Cells and Contracts Regulatory T Cells in systemic Lupus Erythematosus. J Immunol. 2014;192(9):4134\u201344. https:\/\/doi.org\/10.4049\/jimmunol.1301859.","journal-title":"J Immunol"},{"issue":"5","key":"3437_CR41","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.4049\/jimmunol.1301005","volume":"191","author":"Z-W Lai","year":"2013","unstructured":"Lai Z-W, Borsuk R, Shadakshari A, Yu J, Dawood M, Garcia R, Francis L, Tily H, Bartos A, Faraone SV, et al. Mechanistic target of Rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic Lupus Erythematosus. J Immunol. 2013;191(5):2236\u201346. https:\/\/doi.org\/10.4049\/jimmunol.1301005.","journal-title":"J Immunol"},{"issue":"3","key":"3437_CR42","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1084\/jem.166.3.798","volume":"166","author":"CO Jacob","year":"1987","unstructured":"Jacob CO, van der Meide PH, McDevitt HO. Vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to Gamma Interferon. J Exp Med. 1987;166(3):798\u2013803. https:\/\/doi.org\/10.1084\/jem.166.3.798.","journal-title":"J Exp Med"},{"key":"3437_CR43","doi-asserted-by":"publisher","unstructured":"Xiao C, Lv C, Sun S, Zhao H, Ling H, Li M, Qin Y, Zhang J, Wang J, Yang X. TSP1 is the essential domain of SEMA5A involved in Pannus formation in rheumatoid arthritis. Rheumatology. 2021;keab133. https:\/\/doi.org\/10.1093\/rheumatology\/keab133.","DOI":"10.1093\/rheumatology\/keab133"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-024-03437-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-024-03437-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-024-03437-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T15:02:22Z","timestamp":1732028542000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-024-03437-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,19]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3437"],"URL":"https:\/\/doi.org\/10.1186\/s13075-024-03437-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4569696\/v1","asserted-by":"object"}]},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,19]]},"assertion":[{"value":"12 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of the Second Affiliated Hospital of Zhejiang University School of Medicine approved this study (the approval protocol No: 2020433). Before enrollment, all patients gave their written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"204"}}